Cocrystal Pharma (COCP) Change in Inventory (2010 - 2013)
Cocrystal Pharma (COCP) posted Change in Inventory of -$345681.0 for Q3 2013, down 325.24% sequentially from $153469.0 in Q2 2013, and down 237.48% YoY from $251434.0 in Q3 2012.
Cocrystal Pharma (COCP) Change in Inventory (2010 - 2013) Analysis & Trends
Cocrystal Pharma has reported Change in Inventory for 4 years, with the latest figure at -$345681.0 in Q3 2013.
- Quarterly Change in Inventory fell 237.48% year-over-year to -$345681.0 in Q3 2013, while the trailing twelve-month figure through Sep 2013 was -$156562.0 (up 10.21% YoY) and the FY2012 annual result came in at -$237254.0, up 64.37% from the prior year.
- Change in Inventory retreated to -$345681.0 in Q3 2013 per COCP's latest filing, from $153469.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $713298.0 in Q4 2010 and troughed at -$629581.0 in Q2 2012.
- A 4-year average of -$50007.9 and a median of $62879.0 in 2012 frame the typical range for Change in Inventory.
- The widest YoY moves for Change in Inventory: up 145.76% in 2012, down 434.49% in 2012.
- Over 4 years, Change in Inventory stood at $713298.0 in 2010, then plunged by 82.37% to $125763.0 in 2011, then slumped by 50.0% to $62879.0 in 2012, then sank by 649.76% to -$345681.0 in 2013.
- According to Business Quant data, Change in Inventory over the past three periods registered -$345681.0, $153469.0, and -$27229.0 for Q3 2013, Q2 2013, and Q1 2013 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | -345,681.00 |
| Sep 30, 2013 | -345,681.00 |
| Jun 30, 2013 | 153,469.00 |
| Jun 30, 2013 | 153,469.00 |
| Mar 31, 2013 | -27,229.00 |
| Mar 31, 2013 | -27,229.00 |
| Dec 31, 2012 | 62,879.00 |
| Dec 31, 2012 | 62,879.00 |
| Sep 30, 2012 | 251,434.00 |
| Sep 30, 2012 | 251,434.00 |
| Jun 30, 2012 | -629,581.00 |
| Jun 30, 2012 | -629,581.00 |
| Mar 31, 2012 | 78,014.00 |
| Mar 31, 2012 | 78,014.00 |
| Dec 31, 2011 | 125,763.00 |
| Dec 31, 2011 | 125,763.00 |
| Sep 30, 2011 | -549,459.00 |
| Sep 30, 2011 | -549,459.00 |
| Jun 30, 2011 | 188,223.00 |
| Jun 30, 2011 | 188,223.00 |